In vitro fertilization programs

Follicular fluid mutagenicity. In 24 patients, 12 smoking and 12 nonsmoking, who were treated in an in vitro fertilization program, the mutagenicity of follicular fluid was not influenced by the number of cigarettes smoked. However, urine samples of... 

When recombinant and urinary versions of follicle-stimulating hormone were compared under double-blind conditions in an in vitro fertilization program in a randomized, multicenter study (12), the former was more potent. There were no clinically relevant differences in safety between the two products and no cases of ovarian hyperstimulation syndrome. 

M5. Matson, P. L., Morris, I. D., and Sun, J. G., Serum inhibin as an index of ovarian function in women undergoing pituitary suppression and ovarian stimulation in an in vitro fertilization program. Form. Res. 35,173—177 (1991). 

N2. Nakahara, K., Saito, H., Saito, T., Ito, M., Ohta, N., etal., The incidence of apoptotic bodies in membrana granulosa can predict prognosis of ova from patients participating in in vitro fertilization programs. Fertil. Steril. 68, 312—317 (1997). 

I. (1992). A randomized, comparative study of the efficacy and tolerance of roxithromycin and doxycycline in the treatment of women with positive endocervical cultures for Chlamydia trachomatis and Mycoplasma spp. in an in vitro fertilization program. Diagn. Microbiol. Infect. Dis. 15, 129S-131S. 

G7. Goswami, S. K., Chakravarty, B. N., and Kabir, S. N., Significance of an abnormal response during pituitary desensitization in an in vitro fertilization and embryo transfer program J. Assist. Reprod. Genet. 13, 374-380 (1996). 

Bouve J, De Boever J, Leyseele D, Bosmans E, Dubois P, Kohen F, et al. Direct enzyme immunoassay of estradiol in serum of women enrolled in an in vitro fertilization and embryo transfer program. Clin Chem 1992 38 1409-13. 

---